Physician profile
Scott J Hoffman
NPI 1316197809
$59,234.70
in general payments reported to CMS, 2019-2025
5 companies · $20K in 2025
The $20K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $284 · 2021: $2,040 · 2022: $10K · 2023: $9,745 · 2024: $17K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $45K · Travel and Lodging: $992 · Food and Beverage: $890.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $44,750.00 |
| Travel and Lodging | $991.71 |
| Food and Beverage | $889.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $43,838.40 | 2019-2025 | Vantageview, Navitor, Xience Skypoint |
| Philips North America LLC | $10,625.00 | 2023-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided, Ice 3d |
| Boston Scientific Corporation | $3,987.69 | 2022-2025 | Stingray, General - Vascular Access |
| Edwards Lifesciences Corporation | $493.61 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| W. L. Gore & Associates, INC. | $290.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.